Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
Reset all filters
01 1Centrient Pharmaceuticals
02 6Dr. Reddy's Laboratories
03 1ALP Pharm
04 1Amoli Organics
05 1Apotex Pharmachem
06 2Arch Pharmalabs
07 1Asymchem Laboratories
08 1Aurobindo Pharma Limited
09 3Biocon
10 2Cadila Pharmaceuticals
11 1Changzhou Pharmaceutical Factory
12 1Chromo Laboratories
13 1EPHAR BIOLOGICAL AND CHEMICAL CO LTD
14 1HEC Pharm
15 2Hetero Drugs
16 1Ind Swift Laboratories Limited
17 1Jiangsu Alpha Pharmaceutical Co., Ltd.
18 1Jubilant Generics
19 1Laurus Labs
20 1Lek Pharmaceuticals
21 3Lupin Ltd
22 3MSN Laboratories
23 2Macleods Pharmaceuticals Limited
24 2Mankind Pharma
25 3Morepen Laboratories
26 1Par Pharmaceutical
27 1Pfizer Inc
28 1Raks Pharma
29 1Signa S.A. de C.V.
30 4Sun Pharmaceutical Industries Limited
31 1Teva Pharmaceutical Industries
32 1Torrent Pharmaceuticals Limited
33 1Viatris
34 1Vijayasri Organics Limited
35 1Zhejiang Haisen Pharmaceutical Co., Ltd.
36 1Zhejiang Hisun Pharmaceutical
37 1Zhejiang Jiangbei Pharmaceutical
38 3Zhejiang Neo-Dankong Pharm. Co.,Ltd.
39 4Zydus Lifesciences
Reset all filters
01 1(±)-4-FLUORO-A-(2-METHYL-1-OXOPROPYL)-Y-OXO-N, B-DIPHENYL BENZENE BUTANEAMIDE (PAR4C)
02 1ATORVASTATIN
03 1ATORVASTATIN ATV44 (L1)
04 10ATORVASTATIN CALCIUM
05 4ATORVASTATIN CALCIUM (AMORPHOUS)
06 1ATORVASTATIN CALCIUM (API)
07 1ATORVASTATIN CALCIUM (BUTYLATED HYDROXY ANISOLE PREMIX)
08 1ATORVASTATIN CALCIUM (CRYSTALLINE FORM I)
09 1ATORVASTATIN CALCIUM (CRYSTALLINE)
10 1ATORVASTATIN CALCIUM (FORM P) USP, SEMICRYSTALLINE
11 1ATORVASTATIN CALCIUM (NO BHA PREMIX)
12 1ATORVASTATIN CALCIUM (TRIHYDRATE)
13 1ATORVASTATIN CALCIUM (USP) CRYSTALLINE
14 2ATORVASTATIN CALCIUM AMORPHOUS
15 1ATORVASTATIN CALCIUM AMORPHOUS (NON-STERILE BULK DRUG SUBSTANCE)
16 1ATORVASTATIN CALCIUM AMORPHOUS USP
17 1ATORVASTATIN CALCIUM AMORPHOUS, BULK SUBSTANCE
18 1ATORVASTATIN CALCIUM CRYSTALLINE
19 1ATORVASTATIN CALCIUM CRYSTALLINE USP (ATVR)
20 1ATORVASTATIN CALCIUM GRANULATION
21 1ATORVASTATIN CALCIUM NON-STERILE BULK DRUG SUBSTANCE
22 1ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE USP
23 1ATORVASTATIN CALCIUM STABILIZED
24 3ATORVASTATIN CALCIUM TRIHYDRATE
25 1ATORVASTATIN CALCIUM TRIHYDRATE (FORM I)
26 1ATORVASTATIN CALCIUM TRIHYDRATE (FORM I), USP
27 4ATORVASTATIN CALCIUM TRIHYDRATE USP
28 1ATORVASTATIN CALCIUM TRIHYDRATE [FORM-I] [ATN PROCESS]
29 7ATORVASTATIN CALCIUM USP
30 1ATORVASTATIN CALCIUM USP (AMORPHOUS) [ROUTE CODE - "ACA"]
31 1ATORVASTATIN CALCIUM USP (FORM-I) [ROUTE CODE - AC1]
32 1ATORVASTATIN CALCIUM USP (PROCESS II)
33 1ATORVASTATIN CALCIUM USP FORM-I
34 1ATORVASTATIN CALCIUM(AMORPHOUS)
35 1ATORVASTATIN CALCIUM, NON-STERILE BULK DRUG SUBSTANCES
36 2ATORVASTATIN MAGNESIUM
37 1ATORVASTATIN PROTECTED DIOL
38 1ATORVASTATIN SODIUM NON-STERILE BULK DRUG SUBSTANCE
39 1ATORVASTATION CALCIUM (DRUG SUBSTANCE, NON-STERILE)
40 1LIPITOR (ATORVASTATIN CALCIUM) 10MG, 20MG, 40MG, 80MG ORALTABLETS
Reset all filters
01 1Canada
02 11China
03 1Hong Kong
04 45India
05 1Israel
06 1Mexico
07 1Netherlands
08 1Slovenia
09 3U.S.A
Reset all filters
01 45Active
02 20Inactive
Reset all filters
01 30Complete
02 35Blank
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
GDUFA
DMF Review : Complete
Rev. Date : 2016-05-31
Pay. Date : 2015-08-20
DMF Number : 29520
Submission : 2015-08-03
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-27
Pay. Date : 2013-02-05
DMF Number : 18468
Submission : 2005-06-29
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-07
Pay. Date : 2013-09-25
DMF Number : 23664
Submission : 2010-03-30
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-27
Pay. Date : 2013-02-06
DMF Number : 21125
Submission : 2007-12-14
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2014-01-27
Pay. Date : 2013-01-04
DMF Number : 19997
Submission : 2006-11-27
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2020-02-20
Pay. Date : 2020-01-28
DMF Number : 34423
Submission : 2019-12-31
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25902
Submission : 2012-03-23
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18082
Submission : 2005-02-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18835
Submission : 2005-10-04
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18822
Submission : 2005-09-30
Status : Active
Type : II
12
PharmaCompass offers a list of Atorvastatin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Atorvastatin manufacturer or Atorvastatin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Atorvastatin manufacturer or Atorvastatin supplier.
PharmaCompass also assists you with knowing the Atorvastatin API Price utilized in the formulation of products. Atorvastatin API Price is not always fixed or binding as the Atorvastatin Price is obtained through a variety of data sources. The Atorvastatin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sortis manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sortis, including repackagers and relabelers. The FDA regulates Sortis manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sortis API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sortis manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sortis supplier is an individual or a company that provides Sortis active pharmaceutical ingredient (API) or Sortis finished formulations upon request. The Sortis suppliers may include Sortis API manufacturers, exporters, distributors and traders.
click here to find a list of Sortis suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sortis DMF (Drug Master File) is a document detailing the whole manufacturing process of Sortis active pharmaceutical ingredient (API) in detail. Different forms of Sortis DMFs exist exist since differing nations have different regulations, such as Sortis USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sortis DMF submitted to regulatory agencies in the US is known as a USDMF. Sortis USDMF includes data on Sortis's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sortis USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sortis suppliers with USDMF on PharmaCompass.
We have 39 companies offering Sortis
Get in contact with the supplier of your choice: